biophen rivaroxaban plasma calibrator (Sysmex Corporation)
90
Structured Review
Sysmex Corporation
biophen rivaroxaban plasma calibrator
Biophen Rivaroxaban Plasma Calibrator, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biophen+rivaroxaban+plasma+calibrator/biophen+rivaroxaban+plasma+calibrator/pm39923284-53-7-18
Average 90 stars, based on 1 article reviews
Biophen Rivaroxaban Plasma Calibrator, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biophen+rivaroxaban+plasma+calibrator/biophen+rivaroxaban+plasma+calibrator/pm39923284-53-7-18
Average 90 stars, based on 1 article reviews
biophen rivaroxaban plasma calibrator - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting in Patients With or Without Heparin Bridging Article Snippet: Biophen Direct Factor Xa Inhibitors We incubated 200 μL of diluted plasma (1:50 with the Tris-NaCl-EDTA buffer at pH 7.85) with 75 μL of human FXa (Hyphen BioMed) for 120 seconds at 37°C, then 75 μL of a specific FXa substrate [CS-11(65)] (Hyphen BioMed) were added to start the reaction on a STA-R Evolution coagulometer (Diagnostica Stago). .. The concentrations of calibrators for the normal therapeutic range of Article Title: Concomitant assessment of rivaroxaban concentration and its impact on thrombin generation. Article Snippet: Background: Reliable assays to measure direct oral anticoagulant (DOAC) levels and their activity in critical situations are needed.. Drug levels alone are not representative of the effect of DOACs on an individual's coagulation.. We developed a technique that provides direct assessment of the global effect of rivaroxaban on the individual's coagulation in addition to plasma concentrations. Article Title: Impact of centrifugation time and pneumatic tube transport on plasma concentrations of direct oral anticoagulants. Article Snippet: Funding information This work was funded by the Department of Clinical Biochemistry, Aarhus University Hospital Abstract Introduction: Rapid results are needed when plasma concentrations of direct oral anticoagulants (DOACs) are required in acute clinical settings.. We evaluated the impact of centrifugation time and pneumatic tube transport on DOAC plasma concentrations with the overall aim of reducing turnaround time.. Methods: Blood samples were spiked with rivaroxaban, apixaban or dabigatran in a low and a high concentration prior to centrifugation for 25 minutes (3163 g) or 5 minutes (3000 g) (n = 20 for each DOAC). other:Article Title: Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study. Article Snippet: Background: Dielectric blood coagulometry (DBCM) is a coagulation test based on dielectric permittivity.. We recently developed a new cartridge to evaluate the anticoagulation effect of factor Xa inhibitors and investigated the usefulness of this system in the clinical setting.. Here, we evaluate the relationship among the coagulation time measured by DBCM, plasma concentrations of factor Xa inhibitors, and peak thrombin generation using blood samples from patients prescribed factor Xa inhibitors undergoing elective surgery. Concentration Assay:Article Title: Impact of centrifugation time and pneumatic tube transport on plasma concentrations of direct oral anticoagulants. Article Snippet: Funding information This work was funded by the Department of Clinical Biochemistry, Aarhus University Hospital Abstract Introduction: Rapid results are needed when plasma concentrations of direct oral anticoagulants (DOACs) are required in acute clinical settings.. We evaluated the impact of centrifugation time and pneumatic tube transport on DOAC plasma concentrations with the overall aim of reducing turnaround time.. Methods: Blood samples were spiked with rivaroxaban, apixaban or dabigatran in a low and a high concentration prior to centrifugation for 25 minutes (3163 g) or 5 minutes (3000 g) (n = 20 for each DOAC). |